These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 4060828

  • 1. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M, Breithardt G.
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [Abstract] [Full Text] [Related]

  • 2. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M, Kuhl AJ, Lüderitz B.
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [Abstract] [Full Text] [Related]

  • 3. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V, Ickrath O, Schmid F, Mayer F, Haasis R, Seipel L.
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [Abstract] [Full Text] [Related]

  • 4. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P, Manz M, Schütz R, Lüderitz B.
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [Abstract] [Full Text] [Related]

  • 5. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G, Furlanello F, Vergara G, Guarnerio M, Braito G, Nassivera E.
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [Abstract] [Full Text] [Related]

  • 6. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M, Beermann J, Gerckens U, Lüderitz B.
    Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
    [Abstract] [Full Text] [Related]

  • 7. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V, Mewis C, Mayer F, Seipel L.
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK, Prasad GS, Mohan JC, Arora R, Khalilullah M.
    Indian Heart J; 1991 Oct; 43(1):5-10. PubMed ID: 1894303
    [Abstract] [Full Text] [Related]

  • 10. Tachycardia cycle length and maximum capacity of anterograde and retrograde atrioventricular conduction in paroxysmal supraventricular tachycardia.
    Sadr-Ameli MA, Lacombe P, Fromer M, Nadeau R, Shenasa M.
    Can J Cardiol; 1988 Apr; 4(3):134-9. PubMed ID: 3378196
    [Abstract] [Full Text] [Related]

  • 11. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF.
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A, Tani M, Mizumaki K, Shimono M, Inoue H.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [Abstract] [Full Text] [Related]

  • 13. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
    Weismüller P, Kattenbeck K, Heinroth KM, Ranke C, Trappe HJ.
    Dtsch Med Wochenschr; 2000 Aug 18; 125(33):961-9. PubMed ID: 10994404
    [Abstract] [Full Text] [Related]

  • 14. [Effects of oral sotalol on the conduction of accessory atrioventricular pathways].
    Blanc JJ, Boschat J, Ollivier JP, Penther P.
    Arch Mal Coeur Vaiss; 1985 Jul 18; 78(7):1097-102. PubMed ID: 3929739
    [Abstract] [Full Text] [Related]

  • 15. [Analysis of changes in repolarization for the differential diagnosis of narrow QRS supraventricular tachycardia and the site of the accessory pathway].
    Fassini G, Riva S, Della Bella P, Carbucicchio C, Tondo C.
    Cardiologia; 1996 Sep 18; 41(9):869-75. PubMed ID: 8983843
    [Abstract] [Full Text] [Related]

  • 16. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
    Krikler DM.
    Minerva Med; 1975 May 26; 66(39):1914-22. PubMed ID: 236526
    [Abstract] [Full Text] [Related]

  • 17. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun 26; 18(3):157-9, 190. PubMed ID: 2086169
    [Abstract] [Full Text] [Related]

  • 18. [Oral propranolol in Wolff-Parkinson-White syndrome. Electrophysiological data].
    Dolla E, Levy S, Cointe R, Moyal C, Bru P, Rossi P, Gérard R.
    Arch Mal Coeur Vaiss; 1991 Jul 26; 84(7):917-21. PubMed ID: 1929709
    [Abstract] [Full Text] [Related]

  • 19. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF, Neuzner J.
    Z Kardiol; 1996 Jul 26; 85 Suppl 6():45-60. PubMed ID: 9064982
    [Abstract] [Full Text] [Related]

  • 20. Sotalol in patients with Wolff-Parkinson-White syndrome.
    Kunze KP, Schlüter M, Kuck KH.
    Circulation; 1987 May 26; 75(5):1050-7. PubMed ID: 3568305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.